Literature DB >> 970772

"e" Antigen, Dane particles, and serum DNA polymerase activity in HBsAg carriers.

S H Hindman, C R Gravelle, B L Murphy, D W Bradley, W R Budge, J E Maynard.   

Abstract

Sera of 103 carriers of hepatitis B surface antigen were assayed for e-antigen and anti-e. Twenty-four were e-antigen-positive, 31 anti-e-positive, and 48 had neither detectable (e-negative). Aminotransferases were elevated in 75% of the e-antigen-positive carriers compared with 25% of e-negative carriers (P less than 0.001) and 13% of anti-e-positive carriers (P less than 0.001). Serum DNA polymerase activity was significantly higher in the e-antigen-positive carriers than in carriers without e-antigen. Dane particles were shown in 10 of 12 carriers with e-antigen, compared with one of 12 e-negative carriers (P less than 0.0003) and none of 12 anti-e-positive carriers (P less than 0.00003). These results suggest that ongoing hepatitis B viral replication is more active in e-antigen-positive carriers than in carriers without e-antigen, a finding that may help explain the high prevalence of chronic active hepatitis described in these individuals.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 970772     DOI: 10.7326/0003-4819-85-4-458

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  17 in total

1.  Long-term hepatitis B vaccine in infants born to hepatitis B e antigen positive mothers.

Authors:  Y Poovorawan; S Sanpavat; S Chumdermpadetsuk; A Safary
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1997-07       Impact factor: 5.747

2.  Detection of hepatitis B virus DNA in serum by polymerase chain reaction amplification and microtiter sandwich hybridization.

Authors:  G H Keller; D P Huang; J W Shih; M M Manak
Journal:  J Clin Microbiol       Date:  1990-06       Impact factor: 5.948

3.  Radioimmunoassay in the detection of the hepatitis B e antigen/antibody system in asymptomatic carriers of hepatitis B surface antigen. Correlation with serum Dane particle associated DNA polymerase activity.

Authors:  G Pastore; A R Zanetti; P Ferroni; P Dentico; G Angarano; O Schiraldi
Journal:  Infection       Date:  1979       Impact factor: 3.553

4.  The significance of the HBeAg/anti-HBe system in hemodialysis patients. A multicenter study.

Authors:  F Fiaccadori; S David; G Faggion; N Feriani; C Ferrari; V Franco; T Giuberti; C Grutta D'Auria; G La Greca; G Magnani
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

5.  Hepatitis B infection in institutionalized Down's syndrome inmates: a longitudinal study with five hepatitis B virus markers.

Authors:  R A Hawkes; C R Boughton; D R Schroeter; R H Decker; L R Overby
Journal:  Clin Exp Immunol       Date:  1980-06       Impact factor: 4.330

6.  Quantitation of HBeAG and anti-HBe by RIA in sera of chronic HBsAG carriers and individuals with type B hepatitis.

Authors:  W Arnold; G Hess; H Kawakami; K H Meyer zum Büschenfelde
Journal:  Klin Wochenschr       Date:  1981-06-15

7.  Specialty conference: Chronic hepatitis B.

Authors: 
Journal:  West J Med       Date:  1978-04

8.  Hepatitis B e-antigen and its correlation with other serological markers in chimpanzees.

Authors:  C M Ling; I K Mushahwar; L R Overby; K R Berquist; J E Maynard
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

9.  HBsAg-positive chronic liver disease: inhibition of DNA polymerase activity by vidarabine.

Authors:  R G Chadwick; M F Bassendine; E M Crawford; H C Thomas; S Sherlock
Journal:  Br Med J       Date:  1978-08-19

10.  Hepatitis B e-antigen titres for evaluating infectivity during hepatitis B virus infection.

Authors:  E G Lindenschmidt; C F Granato; C Salefsky; R Laufs; H Henning
Journal:  Klin Wochenschr       Date:  1984-03-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.